Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 009789
Company: MEDPOINTE PHARM HLC
Company: MEDPOINTE PHARM HLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MYLAXEN | HEXAFLUORENIUM BROMIDE | 20MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |